Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PPARδ modulators(Peroxisome proliferator-activated receptor delta modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H27F3N2O4 |
InChIKeyGYNMVDMBFKGCCR-QGZVFWFLSA-N |
CAS Registry2095128-17-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Muscular Dystrophy, Duchenne | Preclinical | JP | - | |
Muscular Dystrophy, Duchenne | Preclinical | US | - | |
Muscular Dystrophy, Duchenne | Preclinical | IN | - | |
Renal injury | Preclinical | US | - | |
Renal injury | Preclinical | JP | - | |
Renal injury | Preclinical | IN | - |